Ravi K. Jalluri
Pharmacy in Avondale, PA
License number
Pennsylvania A7-0002163
Issued Date
Aug 3, 2007
Expiration Date
Aug 3, 2017
Category
Pharmacy
Type
Pharmacist - Intern
Address
Address
2
Avondale, PA 19311
Personal information
See more information about Ravi K. Jalluri at radaris.comName
Address
Phone
234 Honey Locust Dr, Avondale, PA 19311
Kennett Sq, PA
234 Honey Locust Dr, Avondale, PA 19311
234 Honey Locust, Kennett Square, PA 19348
Professional information
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors
US Patent:
2011022, Sep 15, 2011
Filed:
Mar 30, 2011
Appl. No.:
13/076176
Inventors:
James D. Rodgers - Landenberg PA, US
Stacey Shepard - Voorhees NJ, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Jordan S. Fridman - Newark DE, US
Krishna Vaddi - Hockessin DE, US
Stacey Shepard - Voorhees NJ, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Jordan S. Fridman - Newark DE, US
Krishna Vaddi - Hockessin DE, US
International Classification:
A61K 31/519, A61K 31/704, A61K 31/675, A61K 31/7048, A61K 31/573, A61K 31/69, A61P 35/00, A61P 43/00, A61P 35/02, A61P 9/00
US Classification:
514 27, 5142651, 514 34, 514110, 514171, 514 64
Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Substituted Cyclic Hydroxamates As Inhibitors Of Matrix Metalloproteinases
US Patent:
2011022, Sep 15, 2011
Filed:
May 19, 2011
Appl. No.:
13/111426
Inventors:
Yun-Long Li - Wilmington DE, US
Jincong Zhuo - Boothwyn PA, US
David Burns - Philadelphia PA, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Jincong Zhuo - Boothwyn PA, US
David Burns - Philadelphia PA, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
International Classification:
A61K 31/397, C07D 405/14, A61K 31/4545, A61K 31/496, C07D 401/14, C07D 401/06, A61K 31/454, C07D 413/14, A61K 31/5377, A61K 31/55, A61K 31/4709, A61P 19/02, A61P 35/00, A61P 9/00, A61P 17/00, A61P 37/08
US Classification:
51421018, 546187, 514316, 544364, 51425311, 546193, 514318, 546208, 514326, 544130, 5142308, 5142372, 540598, 51421705, 546153, 514312
Abstract:
The present invention provides compounds of the formula:its enantiomers, diastereomers, racemic mixtures thereof, prodrugs, crystalline forms, non-crystalline forms, amorphous forms thereof, solvates thereof, metabolites thereof, and pharmaceutically acceptable salts, wherein the ring A substituent groups are fully defined in the following disclosure. The compounds of formula are inhibitors of metalloproteases such as matrix metalloproteases and sheddases, and are useful in treating diseases such as rheumatoid arthritis, psoriasis, neoplastic diseases, allergies and all those diseases wherein inhibition of MMPs is desirable.
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors
US Patent:
2013013, May 30, 2013
Filed:
Jan 30, 2013
Appl. No.:
13/754533
Inventors:
Stacey Shepard - Wilmington DE, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Jordan S. Fridman - Newark DE, US
Krishna Vaddi - Kennett Square PA, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Jordan S. Fridman - Newark DE, US
Krishna Vaddi - Kennett Square PA, US
Assignee:
INCYTE CORPORATION - Wilminton DE
International Classification:
A61K 31/541, C07D 471/04, A61K 31/519, C07D 487/04, A61K 31/5377, A61K 31/513
US Classification:
5142285, 546113, 514300, 544333, 514256, 544280, 5142651, 544117, 5142342, 544 582, 435184
Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors
US Patent:
2014000, Jan 2, 2014
Filed:
Sep 6, 2013
Appl. No.:
14/020505
Inventors:
Stacey Shepard - Wilmington DE, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Jordan S. Fridman - Newark DE, US
Krishna Vaddi - Kennett Square PA, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Jordan S. Fridman - Newark DE, US
Krishna Vaddi - Kennett Square PA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C07D 487/04
US Classification:
5142651
Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Pyrazolyl Substituted Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors
US Patent:
8415362, Apr 9, 2013
Filed:
Jun 12, 2008
Appl. No.:
12/138082
Inventors:
James D. Rodgers - Landenberg PA, US
Stacey Shepard - Wilmington DE, US
Thomas P. Maduskuie - Wilmington DE, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Stacey Shepard - Wilmington DE, US
Thomas P. Maduskuie - Wilmington DE, US
Haisheng Wang - Hockessin DE, US
Nikoo Falahatpisheh - Wilmington DE, US
Maria Rafalski - Greenville DE, US
Argyrios G. Arvanitis - Kennett Square PA, US
Louis Storace - Middletown DE, US
Ravi Kumar Jalluri - Avondale PA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C07D 487/04, A61K 31/519, A61K 31/437, C07D 471/04, A61P 35/00, A61P 29/00
US Classification:
5142651, 544280, 514300, 546113
Abstract:
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines of Formula I:.
Triazolotriazines As Kinase Inhibitors
US Patent:
7683060, Mar 23, 2010
Filed:
Aug 6, 2007
Appl. No.:
11/834226
Inventors:
Jincong Zhuo - Boothwyn PA, US
Colin Zhang - Ambler PA, US
Meizhong Xu - Hockessin DE, US
Ding-Quan Qian - Newark DE, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Colin Zhang - Ambler PA, US
Meizhong Xu - Hockessin DE, US
Ding-Quan Qian - Newark DE, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C07D 487/04, C07D 403/04, C07D 403/14, A61K 31/53, A61K 31/5377, A61P 35/00
US Classification:
514243, 544184, 544112, 5142315
Abstract:
The present invention is directed to [1,2,4]triazolo[4,3-b][1,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Triazolotriazines As Kinase Inhibitors
US Patent:
7915408, Mar 29, 2011
Filed:
Jan 28, 2010
Appl. No.:
12/695636
Inventors:
Jincong Zhuo - Boothwyn PA, US
Colin Zhang - Ambler PA, US
Meizhong Xu - Hockessin DE, US
Ding-Quan Qian - Newark DE, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Colin Zhang - Ambler PA, US
Meizhong Xu - Hockessin DE, US
Ding-Quan Qian - Newark DE, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 31/53, A61K 31/5377, A61P 35/00, C07D 487/04, C07D 403/04, C07D 403/14
US Classification:
544184, 514243
Abstract:
The present invention is directed to [1,2,4]triazolo[4,3-b][1,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Substituted Cyclic Hydroxamates As Inhibitors Of Matrix Metalloproteinases
US Patent:
7973041, Jul 5, 2011
Filed:
Feb 15, 2008
Appl. No.:
12/070310
Inventors:
Yun-Long Li - Newark DE, US
Jincong Zhuo - Marcus Hook PA, US
David M. Burns - Philadelphia PA, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Jincong Zhuo - Marcus Hook PA, US
David M. Burns - Philadelphia PA, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 31/497
US Classification:
51425213, 51425501
Abstract:
The present invention provides compounds of the formula:.
Triazolotriazines As Kinase Inhibitors
US Patent:
8143251, Mar 27, 2012
Filed:
Feb 24, 2011
Appl. No.:
13/033918
Inventors:
Jincong Zhuo - Boothwyn PA, US
Colin Zhang - Ambler PA, US
Meizhong Xu - Hockessin DE, US
Ding-Quan Qian - Newark DE, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Colin Zhang - Ambler PA, US
Meizhong Xu - Hockessin DE, US
Ding-Quan Qian - Newark DE, US
Wenqing Yao - Kennett Square PA, US
Ravi Kumar Jalluri - Avondale PA, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
A61K 31/53, A61P 35/00, C07D 487/04, C07D 403/04, C07D 403/14
US Classification:
514243, 544184
Abstract:
The present invention is directed to [1,2,4]triazolo[4,3-b][1,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Tetracyclic Inhibitors Of Janus Kinases
US Patent:
2006010, May 18, 2006
Filed:
Apr 27, 2005
Appl. No.:
11/115702
Inventors:
James Rodgers - Landenberg PA, US
Darius Robinson - Wilmington DE, US
Thomas Maduskuie - Wilmington DE, US
Stacey Shepard - Voorhees NJ, US
Louis Storace - Middletown DE, US
Haisheng Wang - Hockessin DE, US
Maria Rafalski - Wilmington DE, US
Ravi Jalluri - Avondale PA, US
Andrew Combs - Kennett Square PA, US
Matthew Crawley - Swathmore PA, US
Darius Robinson - Wilmington DE, US
Thomas Maduskuie - Wilmington DE, US
Stacey Shepard - Voorhees NJ, US
Louis Storace - Middletown DE, US
Haisheng Wang - Hockessin DE, US
Maria Rafalski - Wilmington DE, US
Ravi Jalluri - Avondale PA, US
Andrew Combs - Kennett Square PA, US
Matthew Crawley - Swathmore PA, US
International Classification:
A61K 31/503, A61K 31/519, C07D 487/14
US Classification:
514248000, 514257000, 544233000, 544247000
Abstract:
The present invention provides compounds that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases and cancer.